We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DeLauro Sets Sights on Increased Drug Safety Oversight
DeLauro Sets Sights on Increased Drug Safety Oversight
January 23, 2007
Rep. Rosa DeLauro (D-Conn.), the incoming chairwoman of the subcommittee with jurisdiction over the FDA’s budget, has a number of changes in mind for the agency, starting with an improved drug review system, the lawmaker says.